1. Strategy of Research Program: Consolidation, Convergence, Innovation and Translational Applications

The strategy of research development under the support of this fund is to strengthen and upgrade of the research activity by forging the research energy of both basic and clinical faculty members with strong coordination, interaction, synergism and directionality. Support from the previous period allows us to focus on two of the most important research fields in 21st century: genomics and brain science. These two fields represent complex science with integration of different scientific disciplines and with potential innovations for health applications and biotechnological developments. In this first funding period we are mainly consolidating the research activities in the campus and building foundation as well as adjusting to the rapidly developing frontier by developing new research directions that will be both innovative and competitive internationally. The emerging fruitful collaborations, especially between clinicians and basic scientists, the free exchange of ideas and materials, as well as the burst of innovative discoveries testify the success of this approach. It also demonstrates the success of the funding in promoting and advancing university research to be competitive at international level.

From the long period of diversification of scientific field development, the time has come for convergence of these different mature disciplines into new innovations. Convergence does not mean just borrowing technology from other fields but must truly merge in concepts towards “paradigm shift”. To follow this direction, we have initiated in the first funding period the third center, namely Medical Biophotonics , which is an emerging new inter-disciplinary research area with potential innovative medical applications, for possible future convergence with the two established centers. Because of the limitation of physical sciences and engineering in our campus we propose to strengthen this field by collaborating and complementation with National Jiao-Tung and Tsin-Hwa Universities. Based on the successful examples of the two research centers in the previous funding period, we propose to set up two additional centers: Immunity and Biomedical Engineering for further integration of the research activity of this university. Both of these two fields are well developed in this university and recently have achieved innovative discoveries and in particular Biomedical Engineering has further strengthened by forming alliance with UCSD. Consolidation of these two fields in this university not only will further advance the already excellent research activity but will also lead to convergence with the two already well-developed centers for the generation of innovative, interdisciplinary concepts and technologies for biomedical and biotechnological translational applications. Thus we plan to not only consolidate the research activity of this university but to forge two innovative research directions through the convergence of different research areas that include genomics, computational biology, bio-imaging, biosenors, biomechanics, neurobiology, and immunology. An example of convergent research using these diverse knowledge and technology is the study of the “double-edged sword” forkhead transcription factor master regulators which are involved in human language development and evolution, cancer metastasis, metabolic diseases and immune response modulations such as septic shock which is a difficult medical problem with high mortality.

Support under the renewed program not only will make these exciting new advances in science possible but will benefit the society as well by developing new applications both in health care and in biotechnological developments.

2. Facilitation of Industrial, University and Social Development

  • Collaboration with hospitals
  • Collaboration with industries
  • Collaboration with the academia
  • Collaboration in technology transfer.
  • Collaboration in enterprise establishment
  • Promotion of academia-industry collaboration
  • Regional teaching center
  • Cultivation of talent in translational medicine

3. Plans to Develop R&D and Talent in Basic Industrial Technology

  • By hosting biomedical technology conferences to showcase R&D innovations, NYMU enriches the practice of biomedicine with industrial, clinical and academic inputs, facilitating the commercialization of exhibited products. In so doing, the university makes its contribution to the industry of sophisticated medical equipments, one of our nation’s ten fundamental fields for development.
  • NYMU invites leaders of listed or OTC biotech companies in Taiwan to be incubation consultants and share their experience of corporate success to assist faculty and students in their own undertakings
  • NYMU encourages its faculty and students to innovate and to establish enterprises, thereby commercializing R&D results and staying in line with the industry.
  • To help its graduates access the job market, NYMU calls for listed and OTC biotech enterprises to recruit new members on campus.

4. Plans to Collaborate with Other Institutions and to Integrate External Resources

  • UST
  • Reinforced collaboration with research institutes
  • Taiwan’s biomedical park
  • Cross-industrial collaboration
  • Integrated hospital resources
  • Cultivation of research teachers